These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The breakdown of the cytokine network subsequent to human immunodeficiency virus infection. Clerici M; Villa ML; Trabattoni D; Shearer GM Mediators Inflamm; 1995; 4(5):315-21. PubMed ID: 18475658 [TBL] [Abstract][Full Text] [Related]
6. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. Orandle MS; Williams KC; MacLean AG; Westmoreland SV; Lackner AA J Virol; 2001 May; 75(9):4448-52. PubMed ID: 11287599 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of human immunodeficiency virus infection using an immunoglobulin E-based assay. Fletcher M; Miguez-Burbano MJ; Shor-Posner G; Lopez V; Lai H; Baum MK Clin Diagn Lab Immunol; 2000 Jan; 7(1):55-7. PubMed ID: 10618277 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211). Shearer WT; Kline MW; Abramson SL; Fenton T; Starr SE; Douglas SD Clin Diagn Lab Immunol; 1999 May; 6(3):311-5. PubMed ID: 10225828 [TBL] [Abstract][Full Text] [Related]
9. Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Katial RK; Sachanandani D; Pinney C; Lieberman MM Clin Diagn Lab Immunol; 1998 Jan; 5(1):78-81. PubMed ID: 9455885 [TBL] [Abstract][Full Text] [Related]
10. Paediatric HIV infection. Sharland M; Gibb D; Tudor-Williams G; Walters S; Novelli V Arch Dis Child; 1997 Apr; 76(4):293-6. PubMed ID: 9166017 [No Abstract] [Full Text] [Related]
11. T helper cell activation and human retroviral pathogenesis. Copeland KF; Heeney JL Microbiol Rev; 1996 Dec; 60(4):722-42. PubMed ID: 8987361 [TBL] [Abstract][Full Text] [Related]
12. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Lucey DR; Clerici M; Shearer GM Clin Microbiol Rev; 1996 Oct; 9(4):532-62. PubMed ID: 8894351 [TBL] [Abstract][Full Text] [Related]
13. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. Viganó A; Principi N; Villa ML; Riva C; Crupi L; Trabattoni D; Shearer GM; Clerici M J Pediatr; 1995 Mar; 126(3):368-74. PubMed ID: 7869194 [TBL] [Abstract][Full Text] [Related]
14. Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts. Vigano A; Balotta C; Trabattoni D; Bricalli D; Crupi L; Palomba E; Galli L; Salvaggio A; Fusi ML; Ruzzante S; Massironi E; Colombo MC; Principi N; Galli M; Clerici M Pathobiology; 1997; 65(4):169-76. PubMed ID: 9396039 [TBL] [Abstract][Full Text] [Related]
15. Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus. Lee BN; Lu JG; Kline MW; Paul M; Doyle M; Kozinetz C; Shearer WT; Reuben JM Clin Diagn Lab Immunol; 1996 Sep; 3(5):493-9. PubMed ID: 8877124 [TBL] [Abstract][Full Text] [Related]
16. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Douglas SD; Durako S; Sullivan KE; Camarca M; Moscicki AB; Wilson CM Clin Diagn Lab Immunol; 2003 May; 10(3):399-404. PubMed ID: 12738638 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological disease progression in vertically acquired paediatric HIV infection. Gray L Med Wieku Rozwoj; 2003; 7(4 Pt 1):437-48. PubMed ID: 15010554 [TBL] [Abstract][Full Text] [Related]